FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Padmasini Kumar

Research Profile

Chemicals & Drugs

Procedures

Phenomena

RNA Interference

Physiology

Disorders

Concepts & Ideas

Drug Dose Response Relationship

Co-author Network

Publications

TOP 3
Donald D Rao; Neil Senzer; Zhaohui Wang; Chris M Jay; Padmasini Kumar; John Nemunaitis
Bifunctional short hairpin RNA (bi-shRNA): design and pathway to clinical application.
Neil Senzer; David M Shanahan; Nicolas Taquet; Gladice Wallraven; Zhaohui Wang; Yang Yu; Fabienne Norvell; Jonathan Oh; Beena O Pappen; Connor Phalon; Donald D Rao; Minal Barve; Cynthia Bedell; Peter Beitsch; F Charles Brunicardi; Candice Higgs; Chris M Jay; J Kuhn; Padmasini Kumar; Martin Lazar; Samuel Lifshitz; Mitchell Magee; Phillip B Maples; Anton Melnyk; Susan W Mill; John Nemunaitis
Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer.
Anagha P Phadke; Donald D Rao; Stephanie Scott; Neil Senzer; Nancy S Templeton; Zhaohui Wang; Craig Webb; Francis Charles Brunicardi; Salina Chen; Egeenee Q Daniels; Dawna Dylewski; Hermann B Frieboes; Courtney Haddock; Chris M Jay; Padmasini Kumar; Shengnan Liu; Phillip B Maples; David Monsma; John Nemunaitis; Beena O Pappen; Alex W Tong
In vivo safety and antitumor efficacy of bifunctional small hairpin RNAs specific for the human Stathmin 1 oncoprotein.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Padmasini Kumar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Donald D Rao; Neil Senzer; Zhaohui Wang; Chris M Jay; Padmasini Kumar; John Nemunaitis
Bifunctional short hairpin RNA (bi-shRNA): design and pathway to clinical application.
Methods in molecular biology (Clifton, N.J.) 2013;942():259-78.
2012: Neil Senzer; David M Shanahan; Nicolas Taquet; Gladice Wallraven; Zhaohui Wang; Yang Yu; Fabienne Norvell; Jonathan Oh; Beena O Pappen; Connor Phalon; Donald D Rao; Minal Barve; Cynthia Bedell; Peter Beitsch; F Charles Brunicardi; Candice Higgs; Chris M Jay; J Kuhn; Padmasini Kumar; Martin Lazar; Samuel Lifshitz; Mitchell Magee; Phillip B Maples; Anton Melnyk; Susan W Mill; John Nemunaitis
Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer.
Molecular therapy : the journal of the American Society of Gene Therapy 2012;20(3):679-86.
2011: Anagha P Phadke; Donald D Rao; Stephanie Scott; Neil Senzer; Nancy S Templeton; Zhaohui Wang; Craig Webb; Francis Charles Brunicardi; Salina Chen; Egeenee Q Daniels; Dawna Dylewski; Hermann B Frieboes; Courtney Haddock; Chris M Jay; Padmasini Kumar; Shengnan Liu; Phillip B Maples; David Monsma; John Nemunaitis; Beena O Pappen; Alex W Tong
In vivo safety and antitumor efficacy of bifunctional small hairpin RNAs specific for the human Stathmin 1 oncoprotein.
DNA and cell biology 2011;30(9):715-26.
2011: Jairo Olivares; Padmasini Kumar; Yang Yu; Phillip B Maples; Neil Senzer; Cynthia Bedell; Minal Barve; Alex Tong; Beena O Pappen; Joseph Kuhn; Mitchell Magee; Gladice Wallraven; John Nemunaitis
Phase I trial of TGF-beta 2 antisense GM-CSF gene-modified autologous tumor cell (TAG) vaccine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(1):183-92.
2009: John Nemunaitis; M Nemunaitis; Neil Senzer; P Snitz; C Bedell; Padmasini Kumar; Beena Pappen; P B Maples; D Shawler; H Fakhrai
Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients.
Cancer gene therapy 2009;16(8):620-4.
2007: John Nemunaitis; Neil Senzer; I Khalil; Yuqiao Shen; Padmasini Kumar; Alex Tong; J Kuhn; J Lamont; M Nemunaitis; D Rao; Yu-An Zhang; Y Zhou; John S Vorhies; Phillip B Maples; C Hill; D Shanahan
Proof concept for clinical justification of network mapping for personalized cancer therapeutics.
Cancer gene therapy 2007;14(8):686-95.
2006: John Nemunaitis; Robert O Dillman; Paul Schwarzenberger; Neil Senzer; Casey Cunningham; Jodi Cutler; Alex Tong; Padmasini Kumar; Beena Pappen; Cody Hamilton; Edward DeVol; Phillip B Maples; Lily Liu; Terry Chamberlin; Daniel L Shawler; Habib Fakhrai
Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(29):4721-30.
2005: Kartik Konduri; Surinder S Sahota; Gavin Babbage; Alex W Tong; Padmasini Kumar; Joseph T Newman; Marvin J Stone
Immunoglobulin M myeloma: evaluation of molecular features and cytokine expression.
Clinical lymphoma 2005;5(4):285-9.
2004: Melva L Gonzalez; Xin Ruan; Padmasini Kumar; Paula Grammas; H Anne Pereira
Functional modulation of smooth muscle cells by the inflammatory mediator CAP37.
Microvascular research 2004;67(2):168-81.
2003: Taunia D Lee; Melva L Gonzalez; Padmasini Kumar; Paula Grammas; H Anne Pereira
CAP37, a neutrophil-derived inflammatory mediator, augments leukocyte adhesion to endothelial monolayers.
Microvascular research 2003;66(1):38-48.
2003: H Anne Pereira; Xin Ruan; Padmasini Kumar
Activation of microglia: a neuroinflammatory role for CAP37.
Glia 2003;41(1):64-72.
2002: Xin Ruan; James Chodosh; Michelle C Callegan; Mary C Booth; Taunia D Lee; Padmasini Kumar; Michael S Gilmore; H Anne Pereira
Corneal expression of the inflammatory mediator CAP37.
Investigative ophthalmology & visual science 2002;43(5):1414-21.
2002: Taunia D Lee; Melva L Gonzalez; Padmasini Kumar; Saritha Chary-Reddy; Paula Grammas; H Anne Pereira
CAP37, a novel inflammatory mediator: its expression in endothelial cells and localization to atherosclerotic lesions.
The American journal of pathology 2002;160(3):841-8.